First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study - Bockstal, V; Shukarev, G; McLean, C (PLOS ONE, 2022)
et al.